| Serum 25 (OH)D concentrations (nmol/L) | ||||
---|---|---|---|---|---|
≥75.0 | 50.0-74.9 | 25.0-49.9 | <25.0 | P for trend | |
All-cause mortality | Â | Â | Â | Â | Â |
Deaths, yes (%) (all = 4481) | 1462/6796 (21.51) | 1645/6993 (23.52) | 1192/4993 (23.87) | 182/718 (25.35) |  |
Model 1 HR (95% CI) P-value | 1.00 | 1.00 (0.91–1.09) 0.91 | 1.20 (1.05–1.36) 0.01 | 1.73 (1.40–2.13) < 0.001 | < 0.001 |
Model 2 HR (95% CI) P-value | 1.00 | 1.19 (1.09–1.30) < 0.001 | 1.79 (1.59–2.02) < 0.001 | 3.04 (2.44–3.79) < 0.001 | < 0.001 |
Model 3 HR (95% CI) P-value | 1.00 | 1.17 (0.95–1.45) 0.14 | 1.71 (1.22–2.40) 0.002 | 1.97 (1.15–3.39) 0.01 | < 0.001 |
CVD mortality | Â | Â | Â | Â | Â |
Deaths, yes (%) (all = 1940) | 655/6796 (9.64) | 686/6993 (9.81) | 521/4993 (10.43) | 78/718 (10.86) |  |
Model 1 HR (95% CI) P-value | 1.00 | 0.96 (0.84–1.10) 0.56 | 1.24 (1.04–1.49) 0.02 | 1.65 (1.21–2.25) 0.002 | 0.01 |
Model 2 HR (95% CI) P-value | 1.00 | 1.15 (1.01–1.32) 0.04 | 1.87 (1.55–2.27) < 0.001 | 2.91 (2.04–4.13) < 0.001 | < 0.001 |
Model 3 HR (95% CI) P-value | 1.00 | 1.06 (0.75–1.49) 0.75 | 1.71 (0.94–3.14) 0.08 | 1.42 (0.70–2.91) 0.33 | 0.12 |